Loading ...HHS Says No Decision on COVID Vaccine Deal With Pfizer, But Questions Persist About $1.24 Billion Contracts
The controversy began after publicly available federal contracting records showed two CDC contract awards to Pfizer with a combined potential value of approximately $1.24 billion for pediatric and adult COVID-19 vaccines during fiscal years 2026 and 2027.
However, U.S. Health Secretary Robert F. Kennedy Jr. pushed back on the publicly available documents, saying the government had not completed the purchases for vaccines. “The claim that CDC has already spent $1.24 billion on COVID-19 vaccines is simply wrong,” Kennedy wrote
Kennedy’s statement addressed a central point of contention by distinguishing between the existence of a contract vehicle and the obligation or expenditure of federal funds. However, several questions remain unanswered.